Russia May Be Too Risky For Some ETF Investors
August 19th 2008 at 2:00pm by Tom Lydon
As many exchange traded funds (ETFs) cover emerging markets, Russia may provide too much risk for some investors despite the until-recent success of these emerging market economies. The Russian economy started off strong this year, but a cloud of risk surrounds the country.
Eli Hoffman for Seeking Alpha reports that the Russian Stock Market rose 4% last week, even in the midst of its ongoing feud with Georgia. The Market Vectors Russia ETF (RSX) is down 19.3% year-to-date and tracks the Russian stock market. However, growth over the past week shows investors are more concerned about oil prices than the conflict with Georgia.
This week, the fund is getting socked. On Monday, the fund lost 1.3% and today, it’s down more than 4% midday. It could have something to do with the fact that last week, it looked like the conflict would come to a close pretty quickly. This week, that doesn’t seem to be the case, reports Joanne Von Alroth for Investor’s Business Daily.
Russia’s current situation illustrates the political risk of investing in emerging markets. The risk of government intervention is ever-present and the country is also facing 15% inflation.
With many positive characteristics, these risks seem to outweigh some of the pluses Russia brings to the table. Lots of natural resources, $600 billion in forex reserves and a growing consumer economy all provide Russia with investment appeal. However, if an investor cannot stomach the risk, then they should not be in areas that have more than the usual.
The SPDR S&P Emerging Europe ETF (GUR) can provide investors with a little more diversified exposure to Russia. This ETF comprises 35.6% Russia; 22.9% UK; 12.2% Poland; and 10.6% Turkey, but is down 22.8% year-to-date.
For more perspective on the conflict, listen to James Traub speak about it on Fresh Air.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.